Medicxi Growth I LP
CIK 1690310 · last filed 2021-12-06
Medicxi Growth I LP is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider bought $1.8M of CNTA on Dec 6, 2021. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.79M
1
1
$1.76M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTA | 10%+ Owner | 93,526 | $40.50 | $3.79M | $1.76M | 1 | 2021-12-06 |
Recent Filings
1 filingNotice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.